ELAN vs SLB · rev $2.74B vs P/E 12, rev $8.97B
Elanco Animal Health (ELAN) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
Latest reported SLB revenue for 2026-06-30 was $8.97B. Net income was $786.0M. Revenue was up 2.9% from 2026-03-31 to 2026-06-30. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
ELAN currently screens at market cap $11.80B. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the ELAN and SLB stock pages for the full models.
Not investment advice.